Form 4: USANA Director Sells Shares

USANA Health Sciences Director Gilbert A. Fuller sold 1,057 shares of common stock for approximately $21.48 per share.

Summary

• Director Gilbert A. Fuller of USANA Health Sciences Inc. (USNA) reported a sale of common stock.
• The transaction involved the disposition of 1,057 shares.
• The shares were sold at a price of $21.4799 per share.
• The total value of the transaction was approximately $22,699.94 (1,057 shares * $21.4799/share).
• Following this transaction, Gilbert A. Fuller beneficially owns 0 shares directly.
• The transaction occurred on November 3, 2025.
• The sale was made pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-scheduled event.

Sentiment

Score: 4

Explanation: A director selling shares, even under a 10b5-1 plan, can be viewed with slight caution by the market, especially when it reduces direct ownership to zero. However, the pre-planned nature mitigates immediate negative sentiment compared to an unannounced, discretionary sale.

Negatives

• An insider, specifically a Director, selling shares can sometimes be perceived negatively by the market, potentially signaling a lack of confidence or a belief that the stock is fully valued.
• The sale reduces the director's direct ownership to zero, which might be viewed as a reduced alignment of interests with shareholders.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider transactions, such as this director's sale, are common occurrences in the public markets. While a sale can sometimes be interpreted as a lack of confidence, the indication that it was made pursuant to a Rule 10b5-1 plan suggests it was a pre-scheduled event, often for personal financial planning, rather than a reaction to new, undisclosed information about the company's performance.

Stakeholder Impact

• Shareholders may interpret the director's sale, particularly the reduction to zero direct ownership, as a signal, though the 10b5-1 plan suggests it's for personal financial management rather than a reflection of company performance.

Key Dates

Recommendation

While an insider sale, particularly one that reduces direct ownership to zero, might typically warrant caution, the explicit mention of a Rule 10b5-1 plan suggests this was a pre-scheduled transaction for personal financial planning rather than a reaction to new, adverse company information. Therefore, it does not provide a strong signal for immediate buying or selling based solely on this filing, warranting a 'hold' recommendation to observe broader company performance and market trends.

Keywords

USANA Health Sciences, USNA, Insider Trading, Form 4, Stock Sale, Director, Gilbert A. Fuller, Equity Transaction, Rule 10b5-1